Deutsche Bank Ag\ Rubius Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.79 - $5.98 $97,354 - $736,939	123,234 Added 460.41%	150,000 $128,000
Q1 2022 May 13, 2022	SELL	$4.25 - $10.4 $100,929 - $246,979	-23,748 Reduced 47.01%	26,766 $147,000
Q4 2021 Feb 11, 2022	SELL	$9.68 - $17.74 $9,951 - $18,236	-1,028 Reduced 1.99%	50,514 $489,000
Q3 2021 Nov 04, 2021	BUY	$17.6 - $25.91 $37,875 - $55,758	2,152 Added 4.36%	51,542 $921,000
Q2 2021 Aug 11, 2021	BUY	$22.26 - $28.43 $111,967 - $143,002	5,030 Added 11.34%	49,390 $1.21 Million
Q1 2021 May 13, 2021	SELL	$8.02 - $32.01 $26,000 - $103,776	-3,242 Reduced 6.81%	44,360 $1.18 Million
Q4 2020 Feb 16, 2021	BUY	$4.23 - $8.73 $26,987 - $55,697	6,380 Added 15.48%	47,602 $361,000
Q3 2020 Nov 12, 2020	BUY	$4.65 - $6.25 $104,838 - $140,912	22,546 Added 120.72%	41,222 $206,000
Q2 2020 Aug 13, 2020	BUY	$4.01 - $6.88 $24,288 - $41,672	6,057 Added 48.0%	18,676 $112,000
Q1 2020 May 14, 2020	SELL	$3.74 - $9.84 $49,734 - $130,852	-13,298 Reduced 51.31%	12,619 $56,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $61,982 - $121,050	8,573 Added 49.43%	25,917 $245,000
Q3 2019 Nov 14, 2019	SELL	$7.85 - $15.75 $48,379 - $97,067	-6,163 Reduced 26.22%	17,344 $135,000
Q2 2019 Aug 14, 2019	SELL	$13.5 - $19.94 $198,544 - $293,257	-14,707 Reduced 38.49%	23,507 $367,000
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $395,976 - $552,338	29,840 Added 356.34%	38,214 $689,000
Q4 2018 Feb 14, 2019	SELL	$13.83 - $22.97 $265,397 - $440,794	-19,190 Reduced 69.62%	8,374 $133,000
Q3 2018 Dec 21, 2021	BUY	$20.06 - $26.94 $64,392 - $86,477	3,210 Added 13.18%	27,564 $662,000
Q3 2018 Nov 14, 2018	BUY	$20.06 - $26.94 $488,541 - $656,096	24,354 New	24,354 $583,000

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account